With the world watching at the World Economic Forum in Switzerland, AstraZeneca announced a bold plan to have zero carbon emissions from its global operations within the next five years. That would accelerate the company’s “decarbonization” plan by more than…
Eisai: Approval of Antiepileptic Drug Fycompa in Japan for Monotherapy and Pediatric Indications for Partial-Onset Seizures, as well as a New Formulation
TOKYO, Jan 23, 2020 – (JCN Newswire) – Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-house developed antiepileptic drug (AED) Fycompa (perampanel) for an additional indication for monotherapy of partial-onset seizures…
Takeda Eyes 12 New Drug Approvals by 2024, Hemophilia Gene Therapy May Not be a Competitor
One year ago, Takeda wrapped up its acquisition of Shire plc, which created one of the largest drug developers focused on rare diseases. Over the past year, the company strived to transform itself into becoming a frontrunner in multiple areas,…
Horizon Therapeutics Wins FDA Approval for First Thyroid Eye Disease Treatment
Ireland’s Horizon Therapeutics became the first to win regulatory approval in the United States for the treatment of Thyroid Eye Diseases, a progressive autoimmune disorder that can threaten the vision of those afflicted. Tuesday afternoon the U.S. Food and Drug…
KT and Samsung Medical Center to Build 5G Smart Hospital
World’s First Application of 5G Technology in Medical Practice Sync Cams Share Real-Time HD Video Footage of Surgery for Teaching 5G Network Base Made Secure for Medical Service Development Enterprise-Dedicated 5G Network Protects Private Medical Info from Hacking SEOUL, South…
TenNor Therapeutics Received FDA Orphan Drug Designation
SUZHOU, China, Jan. 20, 2020 /PRNewswire/ — TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections. Medical devices such as prosthetic joints, central venous catheters and artificial heart valves…
ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask
SAN DIEGO–(BUSINESS WIRE)– ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market. This press release features multimedia. View the full release…
Celltrion’s Ambitious Biosimilar Plan: 10 Launches in 10 Years
Incheon, South Korea-based Celltrion’s chairman Jung Jin Seo announced at last week’s JP Morgan Healthcare Conference the company’s strategy for the next decade. In particular, he indicated plans to launch a biosimilar every year until 2030. Biosimilars are generic versions…
Who are the 10 Most Innovative Biopharma Companies?
As the annual JP Morgan Healthcare Conference draws to a close, let’s celebrate the remarkable innovation that drives the biopharma industry. Here’s a look at the top 10 companies noted in the BioSpace Ideal Employer 2019 survey for being the…
BioNTech Acquires Neon Therapeutics to Bolster Immuno-Oncology Pipeline
Mainz, Germany-based BioNTech announced it was acquiring Cambridge, Massachusetts-based Neon Therapeutics in an all-stock deal valued at about $67 million. Neon’s focus is on neoantigen therapies that have the potential to be both vaccines and T-cell therapeutics. Neoantigens are immune…
